FDA Inspection 1236807 — Medline Industries, LP

Medline Industries, LP — FEI 2125337

The FDA completed an inspection of Medline Industries, LP on April 11, 2024 in North Mankato, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 11, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
North Mankato, MN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
145021 CFR 211.113(a)Procedures for non-sterile drug products
434221 CFR 211.142(b)Storage under appropriate conditions